New Congressional Bill Would Impose 50% Tariff on Chinese Hemp Products, Require Testing of Cannabinoid Imports

Congressmember Val Hoyle (D-OR) has introduced legislation that would impose a 50% tariff on hemp products imported from China and establish mandatory testing requirements for certain imported cannabinoid products.

The measure, H.R. 10929, was introduced October 29 and referred to the House Committee on Ways and Means and is titled the Protecting American Hemp Farmers Act.

The proposal contains two main provisions. The additional tariff would apply specifically to qualifying hemp and cannabinoid products imported from China, while the testing requirement would apply to certain cannabinoid products imported from any country. If enacted, the tariff would take effect 90 days after the law’s enactment.

The bill would require the U.S. International Trade Commission, acting under presidential direction, to establish separate tariff classifications for cannabinoid isolates and distillates, as well as cannabinoids produced naturally, synthetically or through chemical modification. These classifications would be added to the Harmonized Tariff Schedule, which determines how imported goods are categorized and taxed. The legislation specifically identifies delta-8, delta-9 and delta-10 THC as examples of chemically altered cannabinoids.

The legislation’s definition of hemp-derived cannabinoid products would cover products containing cannabinoids extracted or synthesized from cannabis, along with related extracts, isolates and derivatives, when classified under specified tariff categories. That coverage would extend to products that fall outside the federal definition of hemp.

U.S. Customs and Border Protection (CBP) would be required to obtain additional documentation or certifications from importers when necessary to prevent companies from avoiding the tariff by routing shipments through another country. This would also address attempts to evade the duty through repackaging, blending or minor processing outside China.

CBP would work with the Food and Drug Administration (FDA) to establish mandatory testing for imported cannabinoid products intended for human consumption. Testing would screen for heavy metals, including lead, cadmium, mercury and arsenic, along with mold, mycotoxins, pesticide residues, microbial contamination, leftover solvents, synthetic manufacturing byproducts and unidentified compounds.

The bill would also require CBP and the International Trade Commission to publish annual reports on a publicly accessible website detailing cannabinoid imports by source country, product classification, quantity and customs value. Those reports would include testing information and document the extent to which imported shipments were denied entry based on testing results.